T48.6
Poisoning by, adverse effect of and underdosing of antiasthmatics, not elsewhere classified
Clinical Classification Guidelines
Inclusion Terms
- Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor agonists used in asthma therapy
Excludes Type 1
- poisoning by, adverse effect of and underdosing of beta-adrenoreceptor agonists not used in asthma therapy (T44.5)
- poisoning by, adverse effect of and underdosing of anterior pituitary [adenohypophyseal] hormones (T38.8)
Medical Intelligence & Overview
ICD-10 code T48.6 refers to instances where individuals experience poisoning, adverse effects, or underdosing related to antiasthmatic medications. This includes issues arising from drugs used to manage asthma, particularly beta-adrenoreceptor agonists. Such complications can occur due to overdose, incorrect usage, or sensitivity to these medications, emphasizing the importance of proper medical guidance when using asthma treatments.
Causes & Symptoms
Clinical Causes: Excessive intake or overdose of antiasthmatic medications Incorrect usage or administration of inhalers or other delivery devices Sensitivity or allergic reaction to specific components in the medication Inaccurate dosing, such as underdosing or skipping doses Drug interactions that enhance the effects of antiasthmatic medications Accumulation of medication due to impaired metabolism or clearance Misinterpretation of symptoms leading to inappropriate dosing adjustments
Key Symptoms: Nervousness, restlessness, or tremors Rapid heartbeat (tachycardia) Increased blood pressure Chest pain or discomfort Headache or dizziness Nausea or vomiting Difficulty breathing or respiratory distress Muscle cramps or weakness Insomnia or trouble sleeping Rarely, hallucinations or agitation in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of poisoning or adverse effects involves a detailed medical history focusing on medication usage, dosage, and timing. Physical examinations assess vital signs and respiratory status. Laboratory tests, including blood and urine analyses, can detect medication levels and metabolites, helping determine overdose or toxicity. Additional assessments like ECG may be conducted to monitor cardiac effects. Healthcare providers will also evaluate for potential drug interactions or underlying conditions influencing drug metabolism.
Treatment Protocols: Management of poisoning or adverse effects involves prompt medical intervention. Initial steps may include monitoring vital signs and supporting respiratory function. Activated charcoal might be administered if ingestion was recent and significant. Specific treatments may include administering medications like beta-blockers to counteract excessive adrenergic activity or other supportive therapies to stabilize cardiovascular functions. In severe cases, hospitalization with intensive monitoring and interventions is necessary. Follow-up care focuses on adjusting medication regimens to prevent recurrence and educating patients about correct usage and potential risks.
Clinical Advice & FAQs
Billing Guidance
Is T48.6 a billable ICD-10 code?
Yes, T48.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T48.6?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of antiasthmatics, not elsewhere classified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference